Ìì½ò¿Æ¼¼´óѧ·Ö×ÓÉúÎïѧ¸´Ï°×ܽá(12)
±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2015-09-20
²»Í¬ÖÖ×å¡¢²»Í¬¸öÌåµÄ»ùÒò²îÒ죨»ùÒò×éµÄ¶àÑùÐÔ£©ÒÔ¼°“Õý³£”Ó듼²²¡”»ùÒòµÄ²îÒ죬ֻÊÇͬһλµãÉϵÈλ»ùÒòµÄ²îÒ죬ËùÒÔ£¬ÈËÀà»ùÒò×éÈ«ÐòÁÐÀ´×ÔÒ»¸ö“´ú±íÐÔÈËÀà¸öÌ唣¬²»ÊôÓÚÈκι©Ìå¡£
Ñо¿·¢ÏÖ£¬ÈËÀà»ùÒò×éÓëÆäËü¶¯Îï»ùÒò×éÔÚȾɫÌåˮƽÉÏÓГ¹²Ïß”£¨¼´Í¬Ô´£©ÏÖÏó¡£
8. 2 CLONE-BYCLONE·¨ÓëÄñǹ·¨ÐòÁзÖÎö¼¼ÊõµÄ±È½Ï
8. 2. 1 »ùÒò×éDNA´óƬ¶ÎÎÄ¿âµÄ¹¹½¨
½ÍĸÈ˹¤È¾É«Ìå¼¼Êõ£¨yeast artificial chromosome,YAC£©Îª´´ÖÆ»ùÒò×éÎïÀíͼÌṩÁ˼«´óµÄ·½±ã¡£³ýÁËARSÐòÁÐÖ®Í⣬»¹Ó¦¼ÓÈëCENÐòÁУ¬ÒÔÌá¸ßÓÐË¿·ÖÁÑʱµÄÎȶ¨ÐÔ£¬½µµÍ¿½±´Êý¡£
ÓÖÓÃϸ¾úµÄFÖÊÁ£¼°Æäµ÷¿Ø»ùÒò¹¹½¨Ï¸¾úȾɫÌå¿ËÂ¡ÔØÌ壬³ÆÎªBAC£¨Bacterial artificial chromosome£©£¬Æä¿Ë¡ÄÜÁ¦ÔÚ125~150 kb×óÓÒ¡£Ö÷Òª°üÀ¨oriS£¬repE£¨¿ØÖÆFÖÊÁ£¸´ÖÆ£©ºÍparA¡¢parB£¨¿ØÖÆ¿½±´Êý£©µÈ¡£
8. 2.£²£Ã£Ì£Ï£Î£Å££Â£Ù££Ã£Ì£Ï£Î£Å·¨»ùÒò×éÐòÁзÖÎö¼¼Êõ
8. 2. £³Äñǹ·¨»ùÒò×éÐòÁзÖÎö¼¼Êõ¼°Æä¸ÄÁ¼
ÊÜÐòÁзÖÎö¼¼ÊõÏÞÖÆ£¬Ò»´Î²âÐòµÄ³¤¶È²»Äܳ¬¹ý1kb£¬Ä¿Ç°ÍùÍù²ÉÓÃËùνµÄÈ«»ùÒò×éÄñǹ·¨²âÐò¼¼Êõ£¬Ëæ»úÌôÑ¡²åÈë»ùÒò×éDNAµÄÖÊÁ£×ö²âÐò·´Ó¦£¬È»ºóÓüÆËã»ú³ÌÐò½øÐÐÐòÁÐÆ´½Ó¡£
¶Ôij»ùÒò×éÎÄ¿âÈ«²¿¿Ë¡Ƭ¶Î½øÐÐÄ©¶ËÐòÁвⶨÖÐδ²âµ½µÄ¼î»ùÊý£¬¼´È±¿Ú(gap)£¬ÓëÒѲⶨµÄ×ܼî»ùÊýÏà¹Ø¡£Ëæ×ÅÒѲⶨ¼î»ùÊýµÄÔö¼Ó£¬È±¿ÚµÄ×ܼî»ùÊýÄ¿»á°´ÕÕ²´Ëɹ«Ê½µÄÒ»¸öÍÆÂÛ£¨P=e-m£©Ñ¸ËÙ¼õС¡£
ÆäÖÐPΪ»ùÒò×éÖÐij¸ö¼î»ùδ±»²â¶¨µÄ¸ÅÂÊ£¬mΪËù²â¶¨µÄ¼î»ùÊýÓë»ùÒò×é´óСÏà±ÈµÄ±¶Êý¡£mÔ½´óPֵԽС¡£
Äñǹ·¨²âÐòµÄȱµã£º Ëæ×ÅËù²â»ùÒò×é×ÜÁ¿Ôö´ó£¬ËùÐè²âÐòµÄƬ¶Î´óÁ¿Ôö¼Ó£¬¸÷¸öƬ¶ÎÖØµþ³ÉÒ»¸öÁ¬ÐøÌåµÄ¸ÅÂÊÊÇ2n2-2n
¶ÔÄñǹ·¨µÄ¸Ä½ø
(1) Clone contig·¨¡£Ê×ÏÈÓÃÏ¡ÓÐÄÚÇÐø°Ñ´ý²â»ùÒò×é½µ½âΪÊý°ÙkbÒÔÉÏµÄÆ¬¶Î£¬ÔÙ·Ö±ð²âÐò¡£
(2) °Ð±êÄñǹ·¨(direted shotgun)¡£Ê×Ïȸù¾ÝȾɫÌåÉÏÒÑÖª»ùÒòºÍ±ê¼ÇµÄλÖÃÀ´È·¶¨²¿·ÖDNAƬ¶ÎµÄÏà¶ÔλÖã¬ÔÙÖð²½ËõС¸÷Ƭ¶ÎÖ®¼äµÄȱ¿Ú¡£
8. 3±È½Ï»ùÒò×éѧ£¨Comparative genomics£©¼°¹¦ÄÜ»ùÒò×éѧÑо¿
»ùÒò×éµÄÐòÁпɱ»·ÖΪÈýÀࣨһ£©Í¨¹ý±È½ÏÈ·ÖªÆäÉúÀí¹¦Äܵ컣¨¶þ£©ÔÚÊý¾Ý¿âÖÐÓÐÏàÆ¥ÅäµÄµ°°×ÖÊÐòÁУ¬µ«²¢²»ÖªµÀÆä¹¦Äܵ컣¨Èý£©ÔÚÏÖÓÐÊý¾Ý¿âÖÐÕÒ²»µ½ÈκÎÏàÆ¥ÅäµÄµ°°×ÖÊÐòÁеÄлùÒò¡£
8. 3. 1 ͨ¹ý»ùÒò×éÊý¾Ý½øÐÐÈ«¾ÖÐÔ·ÖÎö
µÍµÈÕæºËÉúÎïÈç½Íĸ¡¢Ïß³æÒÔ¼°¸ßµÈÖ²ÎïÄâÄϽ棬²»µ«»ùÒò×é±È½ÏС£¬»ùÒòÃܶȱȽϸߣ¬°ÙÍò¼î»ù¶ÔÖк¬ÓÐ200¸ö»ò¸ü¶àµÄ»ùÒò£¬»ùÒò×é90%ÒÔÉÏÓɳ£È¾É«ÖÊ×é³É¡£
ÈËÀà»ùÒòµÄƽ¾ù³¤¶ÈΪ27kb×óÓÒ£¬º¬ÓÐ8.8¸ö³¤Ô¼145bpµÄÍâÏÔ×Ó£¬ÄÚº¬×ӵij¤¶ÈÈ´´ïµ½3365bp×óÓÒ£¬3’·Ç·ÒëÇø£¨UTR£©µÄƽ¾ù³¤¶ÈΪ770bp£¬5’·Ç·ÒëÇøµÄƽ¾ù³¤¶ÈΪ300bp£¬¿ª·Å¶ÁÂë¿òµÄƽ¾ù³¤¶ÈÖ»ÓÐ1340 bp£¬±àÂë447¸ö°±»ùËá¡£
ÔʼÉúÎïÖе¥¿½±´»ùÒò½Ï¶à£¬Á÷¸ÐÊÈѪ¸Ë¾úÖе¥¿½±´»ùÒòÕ¼88.8%£¬½ÍĸÖÐÕ¼71.4%£¬¹ûÓ¬ÖÐÕ¼72.5%£¬Ïß³æÖÐÕ¼55.2%£¬ÄâÄϽæÖÐÖ»Õ¼Ô¼35.0%¡£
8.3.2ͨ¹ý»ùÒò×éÊý¾Ý½øÐбȽϻùÒò×éѧÑо¿
ÄòÖ³µÀÖ§ÔÌå´øÓÐÒÑÖª×îСµÄ»ùÒò×飬¿ÉÒÀ´ËÈ·¶¨ÄÜ×ÔÎÒ¸´ÖƵÄϸ°û±ØÐèµÄÒ»Ì××îÉٵĺËÐÄ»ùÒò¡£
ÔÚÒ»¸ö²Ù×Ý×ÓÖмÈÓвÎÓëµ°°×ÖʺϳɵĻùÒògatC£¬Ò²ÓвÎÓë£Ä£Î£ÁÖØ×éµÄ»ùÒòrecAºÍrecJ£¬²ÎÓëϸ°ûÔ˶¯µÄ»ùÒòpilU£¬²ÎÓëºËÜÕËáÉúÎïºÏ³ÉµÄ»ùÒòcmkºÍ²ÎÓëÖ¬·¾ËáÉúÎïºÏ³ÉµÄ»ùÒòpgsA1£®
ͨ¹ý¶ÔÄòÖ³µÀÖ§ÔÌåÓëÁ÷¸ÐÊÈѪ¸Ë¾úÕâÁ½¸öÇ×Ôµ¹ØÏµ½ÏÔ¶µÄÉúÎï»ùÒò×éµÄ±È½Ï, ѡȡÆä¹²Í¬µÄ»ùÒò£¨¹²240¸ö£©£¬ÔÙ¼ÓÉÏһЩÆäËû»ùÒò£¬×îºó×é³ÉÒ»Ì׺¬256¸ö»ùÒòµÄ×îС»ùÒò×é¡£
µ¥Ï¸°ûÕæºËÉúÎïÄð¾Æ½Íĸ»ùÒò×éΪ12£¬068kb£¬±Èµ¥Ï¸°ûµÄÔºËÉúÎïºÍ¹Åϸ¾ú´óÒ»¸öÊýÁ¿¼¶¡£
Äð¾Æ½Íĸ»ùÒò×é¹²ÓÐ5887¸öORF£¬±ÈÔºËÉúÎïºÍ¹Åϸ¾úÒª¶àµÃ¶à¡£Äð¾Æ½ÍĸµÄ»ùÒòÃܶÈΪ1¸ö»ùÒò/2kb£¬Ð¡ÓÚÔºËÉúÎïÁ÷¸ÐÊÈѪ¸Ë¾úºÍÄòÖ³µÀÖ§ÔÌåµÈ¡£
Äð¾Æ½ÍĸÊÇ×îСµÄÕæºË»ùÒò×飬ÁÑÖ³½ÍĸÆä´Î£¬ÆäÃܶÈÊÇ1/2.3kb£¬
¼òµ¥¶àϸ°ûÉúÎïÏß³æµÄ»ùÒòÃܶÈΪ1/30kb¡£Äð¾Æ½ÍĸֻÓÐ4%µÄ±àÂë»ùÒòÓÐÄÚº¬×Ó£¬¶øÁÑÖ³½ÍĸÔòÓÐ40%±àÂë»ùÒòÓÐÄÚº¬×Ó¡£
8. 3. 3 ¹¦ÄÜ»ùÒò×éѧÑо¿
Õû¸ö»ùÒò×éÐòÁеĻñµÃΪÉúÎïѧ´øÀ´ÁËÒ»ÖÖ³ÆÎª¹¦ÄÜ»ùÒò×éѧµÄз½·¨£¬¼´ÔÚ»ùÒò×éˮƽÉϲûÃ÷DNAÐòÁеŦÄÜ¡£
ÈËÀàºÍ¸÷ÖÖģʽÉúÎïµÄÈ«³¤cDNA¿Ë¡¶Ô»ùÒòµÄ·¢ÏÖ¼°¹¦ÄÜ·ÖÎö¶¼¼«ÎªÓÐÓã¬Òò´Ë£¬»ñµÃÈ«³¤cDNAµÄ¼¼ÊõºÍ·¢ÏÖÏ¡ÓÐת¼ÎïµÄ¼¼Êõ¶¼½«±»·ÅÔڸ߶ÈÓÅÏȵĵØÎ»¡£
cDNA RACE(cDNAÄ©¶Ë¿ìËÙÀ©Ôö)
ÊÇÓÃÓÚ´ÓÒÑÖªcDNAƬ¶ÎÀ©ÔöÈ«³¤»ùÒòµÄ·½·¨£¬Ëü¸ù¾ÝÒÑÖªÐòÁÐÉè¼Æ»ùÒòƬ¶ÎÄÚ²¿ÌØÒìÒýÎÓÉ¸ÃÆ¬¶ÎÏòÍâ²à½øÐÐPCRÀ©ÔöµÃµ½Ä¿µÄÐòÁС£ÓÃÓÚÀ©Ôö5’¶ËµÄ·½·¨³ÆÎª5’RACE£¬ÓÃÓÚÀ©Ôö3’¶ËµÄ³ÆÎª3’RACE¡£
¿ÎÍâ×÷ÒµÁ˽âÈËÀàµÈ»ùÒò×éѧÑо¿ÄÚÈݺÍÒâÒå¡£
Ïà¹Ø»°Ìâ/·Ö×ÓÉúÎïѧ
2015ÄêÑо¿ÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ ¶«±±´óѧ£¨³õÊÔ£© ·Ö×ÓÉúÎïѧ »ØÒä°æ
2015ÄêÑо¿ÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ ¶«±±´óѧ£¨³õÊÔ£© ·Ö×ÓÉúÎïѧ »ØÒä°æ ·Ö×Ó£ºÌâÐÍÓÐÃû´Ê½âÊÍ¡¢¼ò´ð¡¢ÎÊ´ð Ò»¡¢Ãû´Ê½âÊÍ£¨5·Ö10¸ö£©£º ±àÂëÁ´£¬SNP£¬Ï¸¾úת»¯£¬·Ò룬°©Ö¢£¬DNA¾ÛºÏø£¬¸ÔÆéƬ¶Î£¬Ë³·´×Ó£¬¸´ÖƲ棬»ùÒò£¬ ¶þ¡¢¼ò´ð£¨7·Ö10¸ö£©£º 1¡¢ÔλÔÓ½»ÔÀí£¬ 2¡¢µ°°×ÖʺϳɵĹý³Ì£¬ 3¡¢°ë±£Áô¸´ÖƵĹý³Ì£¬ 4¡¢ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-09-05ÁÉÄþҽѧԺ·Ö×ÓÉúÎïѧ¸´Ï°Ìâ
2011·Ö×ÓÉúÎïѧ¸´Ï°Ìâ Ò»¡¢Ñ¡ÔñÌ⣺ 1£©¡¢µ¥ÏîÑ¡ÔñÌâ 1¡¢Ö¤Ã÷DNAÊÇÒÅ´«ÎïÖʵÄÁ½¸ö¹Ø¼üÐÔʵÑéÊÇ£º·ÎÑ×Á´Çò¾úÔÚÀÏÊóÌåÄڵ;ÐÔºÍT2ÊɾúÌå¸ÐȾ´ó³¦¸Ë¾ú¡£ÕâÁ½¸öʵÑéÖÐÖ÷ÒªµÄÂÛµãÖ¤¾ÝÊÇ£º (a)´Ó±»¸ÐȾµÄÉúÎïÌåÄÚÖØÐ·ÖÀëµÃµ½DNA£¬×÷Ϊ¼²²¡µÄÖ²¡¼Á (b)DNAÍ»±äµ¼Ö¶¾ÐÔɥʧ (c)ÉúÎïÌåÎüÊÕµÄÍâÔ´DNA£¨¶ø²¢ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-07-30ɽ¶«Ê¦·¶´óѧ·Ö×ÓÉúÎïѧÆÚÄ©öλÔÓéÀֵǼÈë¿ÚÏÂÔØÖØµãÕûÀí
1.ºËСÌå½á¹¹£¿ 2.ºËÌÇÌå»îÐÔλµã£¿ 3.DNA¶þ¼¶½á¹¹£¿ 4.ÔºËÉúÎïÓëÕæºËÉúÎï»ùÒò×éµÄ²îÒì 5.ά³ÖDNAË«ÂÝÐýÎȶ¨ÐÔÒòËØ£¿ 6.ÔºËÉúÎïÖеÄDNA¾ÛºÏø(´ó³¦¸Ë¾ú£© 7.ÕæºËÉúÎïµÄRNA¾ÛºÏø¢òµÄÆô¶¯×Ó½á¹¹ÌØµã£¿ 8.ת×ù·¢ÉúµÄ»úÖÆ¡¢ÀàÐÍ¡¢ÒÅ´«Ñ§Ð§Ó¦ 9.Ö¤Ã÷ÒÅ´«ÎïÖÊÊǺËËáµÄʵÑéÒÀ¾ÝÊÇʲô£¿ 10.Éè¼ÆÊµÑéÖ¤Ã÷DNAµÄ°ë±£Áô¸´ÖÆ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-07-192015ɽ¶«Ê¦·¶´óѧ·Ö×ÓÉúÎïѧÆÚÄ©öλÔÓéÀֵǼÈë¿ÚÏÂÔØ»ØÒä
ɽ¶«Ê¦·¶´óѧ 2015Äê·Ö×ÓÉúÎïѧÊÔÌâ»ØÒä Ò»¡¢Åжϣ¨201£© ¶þ¡¢Ãû´Ê½âÊÍ£¨64£© ¹ö»·¸´ÖÆ Í¬¹¤tRNA Èõ»¯×Ó »ùÒòоƬ TBP ÔöÇ¿×Ó Èý¡¢¼ò´ð£¨48£© 1¡¢ÕæºËÓëԺ˻ùÒò×éµÄÇø±ð£¿ 2¡¢×ªÂ¼Òò×ÓÊÇʲô£¿DNA½áºÏÓòµÄÌØµã£¿ 3¡¢Ê²Ã´ÊÇRNA¼ô½Ó£¿Ê²Ã´RNA±à¼£¿ÉúÎïѧÒâÒåÊÇʲô£¿ 4¡¢Ê²Ã´»ùÒòÓ¡¼Ç£¿DNAµÄ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-07-19ÎÖÉ¡¶»ùÒòµÄ·Ö×ÓÉúÎïѧ¡·ÓëÖìÓñÏÍ¡¶ÏÖ´ú·Ö×ÓÉúÎïѧ¡·ÒªµãºÏ²¢
ÔºË ÕæºË DNA½á¹¹ 1.Ë«Á´£¬Ë«ÂÝÐý£¨H¼ü£¬¼î»ù¶Ñ»ýÁ¦£© 2.¼î»ù»¥²¹Åä¶Ô£¬º¬T 3.¼î»ù¿ÉÒÔÍâ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à ÍøÂç×ÊÔ´ 2015-07-16ÖпÆÔº612ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ14Äê5ÄêÕæÌâ
2015Öйú¿ÆÑ§Ôº´óѧ612¡¶Éú»¯Óë·Ö×ÓÉúÎï¡· Ò»¡¢Ãû´Ê½âÊÍ£¨5*4£© Á÷¶¯ÏâǶģÐÍ Ìǽͽâ ÑϽô¿ØÖÆ Ã¸×¨Ò»ÐÔ Ð¡·Ö×Ó¸ÉÈÅRNA ¶þ¡¢µ¥Ñ¡£¨1*20£© Ó¡Ïóµ±ÖкÃÏñ¶¼Ã»¼û¹ý ¶øÇÒ¿¼µÄ¶«Î÷ºÜϸ ¸öÈËÈÏΪÓÐµãÆ« Èý¡¢ÅжÏÌ⣨1*30£© ºÃÏñҲûʲô̫¶àÖØ¸´µÄ ËÄ¡¢¼ò´ðÌ⣨4*5£© 1¡¢Ï¸°ûĤ½á¹¹ÔÚ´úлÖеÄ×÷Óà 2¡¢»ùÒòÇóýÓëRNA¸É ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-07-152015Ä껪ÖпƼ¼´óѧ¡¶Éú»¯Óë·Ö×ÓÉúÎïѧ¡·öλÔÓéÀÖ¹Ù·½appÏÂÔØÕæÌâ
2015Ä껪ÖпƼ¼´óѧ¡¶Éú»¯Óë·Ö×ÓÉúÎïѧ¡·öλÔÓéÀÖ¹Ù·½appÏÂÔØÕæÌ⣨»ØÒä°æ£© Ò»¡¢Ð´³öÏÂÁÐÃû´Ê¶ÔÓ¦µÄÖÐÎIJ¢½âÊÍ£¨Ã¿Ìâ8·Ö£© 1.configurationconformation2.structuraldomainsuper-secondarystructure 3.allostericeffecthyperchromiceffect4.liposomeribosome 5.molecularchaperonemolecularhybridization6.ORFARS 7.transposit ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à ÍøÂç×ÊÔ´ 2015-07-14·Ö×ÓÉúÎïÑ§ÖØÒª¸ÅÄî½âÊÍ
·Ö×ÓÉúÎïÑ§ÖØÒª¸ÅÄî½âÊÍ A Abundance (mRNA ·á¶È)£ºÖ¸Ã¿¸öϸ°ûÖÐmRNA ·Ö×ÓµÄÊýÄ¿¡£ Abundant mRNA (¸ß·á¶ÈmRNA)£ºÓÉÉÙÁ¿²»Í¬ÖÖÀàmRNA×é³É£¬Ã¿Ò»ÖÖÔÚϸ°ûÖгöÏÖ´óÁ¿¿½±´¡£ Acceptor splicing site (ÊÜÌå¼ôÇÐλµã)£ºÄÚº¬×ÓÓÒÄ©¶ËºÍÏàÁÚÍâÏÔ×Ó×óÄ©¶ËµÄ±ß½ç¡£ Acentric fragment (ÎÞ×ÅË¿Á£Æ¬¶Î)£º(ÓÉ´ò¶Ï²úÉúµÄ)ȾɫÌåÎÞ×Å ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à ÍøÂç×ÊÔ´ 2015-07-08Î人´óѧ·Ö×ÓÉúÎïѧÌâ¿â
GLOSSARY Abundance of an mRNA is the average number of molecules per cell. Abundant mRNAs consist of a small number of individual species, each present in a large number of copies per cell. Acceptor splicing sitesee right splicing junction. Acentric fragment of a chromosome (generated by ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-06-21Õã½´óѧ2013-2014·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØÕæÌâ»ØÒä
Í¿öÎèº 2012¼¶ÉúÎï¿ÆÑ§ 2013-2014 ·Ö×ÓÉúÎïѧ¼× »ØÒä Ò»¡¢·Ò루25Ñ¡20£© Nucleosome Telomerase Deoxyribonucleic Acid Ribosome In vivo Eukaryote Transcrption Reconbination PTGS Epigenetics SnRNP RNAi ³ÁĬ¸´ºÏÌå ͬβø ת¼ºó»ùÒò³ÁĬ µ°°×ÖÊ×éѧ ¹¦ÄÜ»ùÒò×éѧ Ó«¹â¹²ÕñÄÜÁ¿´«µÝ ¿ª·ÅÔĶÁ¿ò ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2015-06-06
